Vanguard Global Advisers’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134K Buy
5,686
+1,071
+23% +$30.6K ﹤0.01% 2642
2026
Q2
$127K Hold
4,615
– – ﹤0.01% 2684
2026
Q1
$128K Buy
+4,615
New +$132K ﹤0.01% 2630

Other funds holding ASMB

Vanguard Global Advisers's ASMB Position: Q3 2026 in Review

Vanguard Global Advisers increased its Assembly Biosciences (ASMB) stake by 23% in Q3 2026, buying an estimated $30.6K and bringing the position to 5,686 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

Vanguard Global Advisers first reported a position in ASMB in Q1 2026 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.

  • Vanguard Global Advisers held 5,686 shares of Assembly Biosciences worth $134K as of Q3 2026.
  • Vanguard Global Advisers bought 1,071 Assembly Biosciences shares in Q3 2026, an estimated $30.6K.
  • Assembly Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2642 holding.
  • Vanguard Global Advisers first reported a position in Assembly Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.